Medical Specialties
Urology
Unlock the Future of Prostate Cancer Care with IMS: Introducing a PET Program Featuring Emerging Radioisotopes
The landscape of prostate cancer diagnosis and treatment is undergoing a transformative shift with the advent of new and innovative radioisotopes. These advancements are enhancing the capabilities of Positron Emission Tomography (PET) imaging, allowing for more precise detection and targeted treatment of prostate cancer. At IMS, we are dedicated to bringing a state-of-the-art PET program to your facility, ensuring you can provide your patients with cutting-edge care.
WHY PARTNER WITH IMS FOR YOUR PET PROGRAM?
1. Trusted Partnership
IMS is a leader in the field of PET imaging programs and partnership solutions. Our team of experts is committed to helping you implement a PET program that harnesses the power of new radioisotopes to optimize prostate cancer detection and treatment.
2. Comprehensive Program Development
We provide a full spectrum of services for implementing your PET program. This includes customized program design, equipment procurement, full-service maintenance plan coverage, and expert training for your staff, ensuring seamless integration into your facility.
3. Access to State-of the-Art Technology
By collaborating with IMS, you will be at the forefront of integrating new radioisotopes specifically designed for prostate cancer imaging. Coupling this with state-of-the-art imaging equipment will significantly enhance your diagnostic accuracy, enabling early detection and precise treatment planning.
4. Expand Your Service Offerings
Adding a PET program featuring advanced radioisotopes will diversify and enrich your facility’s oncology services. This capability will not only attract new patients seeking specialized prostate cancer care but also strengthen your reputation as a leader in advanced cancer treatment.
5. Comprehensive Build-0ut Support
From planning and installation to optimization and beyond, IMS provides a complete build-out of your PET program. Our end-to-end support ensures a smooth implementation process, allowing your facility to seamlessly integrate this cutting-edge technology into your existing services.
6. Improved Patient Outcomes
The use of enhanced imaging modalities leads to better staging of prostate cancer, more accurate assessment of treatment response, and improved management of patient care. Ultimately, this means improved survival rates and quality of life for your patients.
STAY AHEAD IN THE EVOLVING FIELD OF IMAGING
As the medical field rapidly develops, staying informed about new technologies and methodologies is essential. By partnering with IMS to launch your PET program, you ensure that your facility remains at the forefront of this evolving imaging field, equipped to provide the best possible care for prostate cancer patients.
READY TO START YOUR JOURNEY?
Contact IMS today to discover how we can help you integrate a groundbreaking PET program featuring emerging radioisotopes into your facility. Together, we can enhance your services and make a meaningful difference in the lives of patients battling prostate cancer.
By introducing an advanced PET program with IMS, your facility can take a significant step forward in the fight against prostate cancer, ensuring your place as a leader in innovative oncology care. Join us in this exciting journey toward excellence in patient care!
Why Cardiac PET/CT?
-
Greater diagnostic accuracy
-
Strong prognostic power
-
Lower radiation exposure
-
Reduced imaging time
-
Improved image quality
-
Myocardial blood flow assessment
"At Cardio Health Solutions our mission is to advance cardiac imaging by providing comprehensive turnkey PET/CT programs that empower healthcare facilities to deliver superior cardiovascular care."
Planning to Scanning
With a proven track record, our team can move from planning to scanning in as little as four months. We offer a low to no-cost investment model, which reduces capital expenditure and minimizes risk for the practice. Cardio Health Solutions handles supplier contracts, removing the burden of commitment from your practice for a smooth, stress-free experience. Our aim is to foster long-term partnerships to expand access to PET /CT services.
Our Deliverables
-
Full turnkey Imagina Solutions
-
Project Management
-
Custom PET/CT Suites
-
Mobile PET/CT Services
-
Physicists Services
-
Generator and Isotope Supply
-
Hazmat Training
-
Clinical Staff Education
-
Revenue Cycle Support
-
Accreditation Support
ASNC / SNMMI Recommendations
Together the American Society of Nuclear Cardiology (ASNC)and the Society of Nuclear Medicine and Molecular Imaging (SNMMI) have issued a position statement that concludes myocardial perfusion PET is preferred and recommended imaging for patient with known or suspected coronary artery disease.
By The Numbers
-
Bateman TM. J Nucl Cardiol. 2012; 19: 3-11
-
Bateman TM et al. J Nucl Cardiol. 2006; 13: 24-33
" We aim to be the trusted partner that streamlines the implementation of cardiac PET/CT programs by offering comprehensive solutions."
